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Collective migration is a basic mechanism of cell translocation during morphogenesis, wound
repair and cancer invasion. Collective movement requires cells to retain cell–cell contacts,
exhibit group polarization with deﬁned front-rear asymmetry, and consequently move as one
multicellular unit. Depending on the cell type, morphology of the group and the tissue context,
distinct mechanisms control the leading edge dynamics and guidance. Leading edge migration
may either result from adhesion to ECM and contractile pulling, or from forward pushing.
The leading edge consists of either one or few dedicated tip cells or a multicellular leading row
that generate adhesion and traction towards the tissue substrate. Alternatively, a multicellular
bud consisting of many cells protrudes collectively by proliferation and growth thereby
mechanically expanding and pushing towards the tissue stroma. Each type of collective
guidance engages distinct spatiotemporal molecular control and feedback towards rearward
cells and the adjacent tissue microenvironment; these include intrinsic polarity mechanisms
regulated by the interplay between cell–cell and cell-ECM interactions; or the heterotypic
integration of stromal cells that adopt leader cell functions. We here classify molecular and
mechanical mechanisms of leading function in collective cell migration during morphogenesis
and wound repair and discuss how these are recapitulated during collective invasion
of cancer cells.
Introduction
Cell migration is a fundamental process leading to the position
change of cells on or within the tissue environment. Cells can
either move individually, termed single-cell migration, or as
multicellular units with cell–cell junctions retained, termed
collective cell migration.1,2 Whereas single-cell migration
depends upon mechanotransduction and signaling cascades
within the same cell, in collective cell migration these func-
tions are shared between diﬀerent cells to reach coordinated,
‘‘supracellular’’ translocation. The morphologies and organi-
zation of moving cell groups vary depending on the cell and
tissue context, ranging from moving multicellular sheets to
clusters, strands, or tubes (Fig. 1). Because of its organized
shape, collective migration is central to the formation of
complex tissue structures, such as glands and epithelia during
morphogenesis and during wound repair (Fig. 1(A)) and, in
less well controlled form, cancer invasion3 (Fig. 1(B)).
Similar to single-cell migration, all collective migration
modes are dependent on polarized actomyosin-driven inter-
action with surrounding tissue structures at the leading edge,
leading to the displacement of cells relative to the substrate. In
single-cell migration, the underlying mechanotransduction
occurs within the same cell body by subcellular formation of
functional zones, i.e. leading edge protrusion and engagement
with the substrate and rear-end retraction leading to translocation
of the cell body. In collective migration, these functions are
coordinated within individual and between neighboring cells
via their cell–cell junctions.2 Thus, cells retain their cell–cell
adhesion and communication to collectively polarize and
migrate directionally. Thereby, the group of cells behaves as
a multi-cellular unit, a ‘‘super-cell’’.
Two morphologically and functionally distinct regions deter-
mine the direction and eﬃciency of collective cell migration,
the leading and trailing edge. The leading edge of moving cell
groups consists of one or several cells, termed pathﬁnder,
leading or tip cells which explore the tissue environment, ﬁnd
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Insight Box
Collective cell migration is a principal migration
mode in morphogenesis, regeneration and cancer which
depends upon complex cell-cell and cell-tissue interactions.
Both, temporary activation and long-lasting diﬀeren-
tiation deﬁne leader cells of moving cell groups to undergo
partial epithelial-to-mesenchymal transition. We here
classify how leader cells guiding migrating cell groups
become selected by intrinsic and extrinsic signals to
polarize, interact with tissue matrix and generate
mechanotransduction.
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the path, generate traction and, where needed, proteolytically
remodel ECM for path generation.4–7 As hallmark, leading
cells are intrinsically bipolar, as their front engages with the
tissue substrate while their rear region remains engaged with
the neighbor cells.8,9 Intrinsic bipolarity is maintained by
mechanotransduction through integrins that engage with extra-
cellular matrix at free pole of the cell and cadherin-based
cell–cell junctions at the other side. In living tissues, this
intrinsic bipolarity receives additional input from extracellular
signals, such as chemokine and growth factor signaling
(Table 1). Using examples from cell movement in morpho-
genesis, epidermal wound repair and cancer invasion we here
ﬁrst classify morphologies and force generation mechanisms in
collective migration and then discuss the signaling control to
select and maintain diﬀerent leader cell types and functions.
Diversity of leading edge morphology and function
The morphology and biomechanics of the leading edge region
can be classiﬁed into diﬀerent types based on the number of
cells that lead the group, how they interact with the ECM
substrate, and their positioning relative to neighboring cells.
Further, distinct leading edge mechanics comprise either
pulling on or pushing towards ECM substrate leading to
physically distinct types of collective movement.
Collective traction
In most cases of collective leader cells, microenvironmental
sensing for guidance cues and mechanotransduction are
mediated by extending ﬁlopodia and/or lamellipodia which
protrude and give rise to focalized adhesions between tissue
structures and the intracellular cytoskeleton.6,10,11 After anterior
attachment, pulling forces towards ECM are generated by
actomyosin-driven contraction of the cell body so that the ECM
is displaced and realigned towards the leading edge of the
group.8,12 Leader cells that generate traction force recapitulate
many characteristics of leading edge mechanics in single cells,
including substrate-induced and directed integrin-mediated
Fig. 1 Diversity of leading edge morphology and function in
collective cell migration. (A) Morphogenesis and tissue regeneration.
Top panel: in epithelial wound healing, epidermal cells migrate as
multicellular sheets maintaining cell–cell contacts (orange). The leading
row (shaded color) is multicellular, extends cytoplasmic protrusions
and guides following cells over the two dimensional substratum in
response to extracellular cues, including growth factors. The leading
row contacts a provisional matrix composed of interstitial ECM
components with diﬀerent physicochemical properties than the newly
secreted basement membrane underlying the trailing cells. Mid panel:
during Drosophila tracheal branching, one or two cells (shared color)
are selected to guide the sprouting of new branch in response to FGF.
FGF upregulates Delta1 expression in the tip cell which in turn binds
to Notch that is localized on the membrane of neighboring stalk cells.
Notch activation leads to the inhibition of FGFR signaling in stalk
cells, preventing the trailing cells to acquire the tip cell phenotype.
Bottom panel: in mammary gland morphogenesis, the terminal end
bud (TEB) leads the invasion of mammary ducts into the mammary
fat pad. The TEB (shaded color) is a multi-layered epithelium which
exhibit high rates of proliferation and cellular rearrangement. While
invading the stroma, TEB transforms into a bilayered duct consisting
of myoepithelial cells and luminal epithelial cells, whereby the diﬀeren-
tiated luminal epithelial cells are covered with a myoepithelial cell
layer and a newly deposited basement membrane. On the other hand,
TEBs have a partial myoepithelial coverage and are surrounded by a
thin basement membrane. Whereas the end bud protrudes mostly
driven by growth, the ducts provide stable rearward anchorage and
lack migration dynamics. Stromal cells including ﬁbroblasts and
macrophage are involved in releasing several soluble factors and
proteases that are essential for the invasion of TEB and duct elonga-
tion yet the signals which induce and maintain directionality of the
ductal elongation are not completely understood. (B) Diversity of
tip-cell morphology in cancer invasion. Provisional model describing
three general forms of malignant collective invasion through the 3D
interstitial tissue, as deduced from morphogenesis.
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adhesion to ECM followed by actomyosin-dependent contrac-
tion of the cell body and retraction of the cell rear.13,14
Depending on the number of leading cells and the substrate
encountered, traction-generating leading edges form distinct
mono-, oligo- or multicellular organisation geometries. A
multicellular broad and ﬂat rim of cells leads epithelial sheet
migration over 2D substratum during the wound closure of
skin or regenerating corneal epithelium (Fig. 1(A)).8,15,16
In sprouting vessels and branching morphogenesis of the
Drosophila tracheal system, one or two leading cells initiate
and guide a strand-like multicellular stalk (Fig. 1(A)), and
similar single-cell tips have been described in collective cancer
invasion (Fig. 1(B)).4,5,7 Likewise, few deﬁned leader cells form
an oligocellular leading group followed by stalk-like collective
strands, as during lateral line migration in the zebraﬁsh embryo
or broad invasive fronts of invasive cancer6,12,17,18 (Fig. 1(B)).
Cells at leading positions further execute pericellular proteolysis
and thereby form or enlarge the physical path of migration.7,19,20
Because of their focalized adhesion and traction force charac-
teristics, leading cells develop an extended, spindle-shaped
morphology with loss of apical basal polarity21 or, on 2D
substrate, a spread-out adhesive morphology with abundant
stress ﬁbers which, together with the engagement of surface
proteases, are characteristics of mesenchymally-moving cells.2,22
In most cases, the leader cells remain in guiding position for
hours and longer23,24 and are stabilized by cellular contact
with the trailing cells through adherens, desmosomal and tight
junctions.25–27 In collective sheet migration, besides the
front row of cells, cells within the group contribute to traction
force generation by forming basal membrane protrusions
(‘‘cryptic lamellipodia’’) that engage with the underlying
substrate and generate active motility.28,29 Because not all
cells always pull into the same direction, the driving force
for collective motion might be the net result integrating
multiple force vectors (‘‘tug-of-war’’) so that supracellular
tensile stress across the cell–cell-junctions moves the group
towards the direction of the leading edge.29
Collective pushing
When the leading region comprises several cells but forms
a blunt smooth rim that lacks actin-rich protrusions and
adhesion sites towards the tissue environment, the known
hallmarks of adhesion and traction force generation mecha-
nisms are lacking; instead, leading bud movement appears to
occur through volume expansion and pushing elongation
(Fig. 1(A)). This mode of protrusion mechanics is obvious
in mammary and embryonic salivary gland formation, yet
mechanistically poorly understood.30,31 Leading buds lack a
leader cell at stably deﬁned position but rather consist of
multiple cells that are mobile and exchange position relative
to their neighbors so they dynamically adapt and rearrange
bud morphology.30,31 Pushing forces and the net movement
may in part result from expansive growth driven by prolifera-
tion of cells within and adjacent to the bud.32 The nature of
cell-matrix interactions at the tip of leading buds is currently
unknown; likewise the mechanism of matrix remodeling for
path generation remain to be identiﬁed yet likely includes the
participation of stromal cells.33
Table 1 Major morphogenesis- and tumor-associated soluble and ECM ligands and their eﬀect on leading edge functions
Ligand Receptor
Intracellular mediators
(GTPases and Kinases) Cellular response References
VEGF VEGFR2 Cdc42/SAPK2 Filopodia and Polarization 71
Rac1/PAK and RhoA Lamellipodia and Stress Fibers 72,73
RhoA, FAK and Rac1/Vav2 Migration 74–76
FGF FGFR Cdc42 Filopodia and Polarization 77
Cdc42/PI3K and ERK Migration 78,79
EGF EGFR Cdc42 Filopodia and Polarization 80
RhoA, RhoC, Vav1/ERK, FAK
and Rac1/Src-PI3K
Migration 81–83
Rac1, Cdc42 Lamellipodia and other Membrane
Protrusions
84
TGF-b TGFR RhoA/PI3K-Akt, RhoB/ERK,
and Cdc42/PAK
Migration 85–87
Cdc42, RhoA Lamellipodia and other Membrane
Protrusions
88
PDGF PDGFR Rac1/PAK , Akt/Rac/Cdc42,
Rap1/Rac1
Migration 89–91
Rac1/PI3K Membrane Ruﬄes 92
SDF-1 CXCR4 Cdc42, PI3K/Akt, Rap,
Rac1-Cdc42/PAK1
Migration 93–96
IGF-1 IGFR PI3K, Rac1 Membrane Ruﬄes, Lamellipodium 97,98
Rac1, ROCK Migration 47,99
ECM Component
N/A Integrin avb3 and avb5 Cdc42/WASP, Rac1/PAK,
RhoA/ROCK, ERK
Migration 100
Laminin-10/11 Integrin a3b1 Rac/p130Cas Lamellipodia and Migration 99
N/A Integrin a6b4 Rac1/TIAM1, PI3K Migration 101,102
Collagen N/A MAPK/MLCK Migration 103
N/A a3b1 Rho, FAK/Src/RAc1 Stress Fibers, Polarization and
Migration
99
N/A a5b1 RhoA Acto-myosin Contraction and
Random Migration
104
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Molecular triggers for leading edge selection
Several mechanisms lead to the formation and maintenance of
leading functions in collective cell migration. These include
intrinsic polarity, diﬀerentiation and heterocellular assistance.
Intrinsic polarity
The most fundamental mechanism generating leading cell
function in multi-cellular migration results from the consti-
tutive front-rear asymmetry governed by the leading edge
engaged with ECM structures and lateral and rear parts
engaged in cell–cell contacts. Thereby a constitutive yet transient
and reversible polarity is generated, here referred to as intrinsic
polarity. Cell–cell contact has long been known to negatively
modulate actin-driven protrusions and migration (contact
inhibition of migration).34,35 Among the cell–cell contact
molecules implicated in contact inhibition of migration are
cadherin-based calcium-dependent junctions that control the
actin cytoskeleton through several actin-regulatory proteins
such as catenins, Rho GTPases, Arp2/3 complex and
Ena/VASP.36,37 On the one hand side, short-term cadherin
engagement activates Rac and Cdc42 which promote protrusive
membrane dynamics, including lamellipodia and ﬁlopodia.38,39
Once stable, however, established cell–cell adhesions
inhibit membrane protrusions in part by activating RhoA
which antagonizes Rac1 activity and thereby actin-mediated
protrusions.40–44 The best-studied model of generating intrinsic
bipolarity in leader cells is the migration of cephalic neural
crest cells which originate as cohesive strand and later dissociate
into to single cell streaming.45 The intrinsic bipolarity of cells
leading the group involves cytoplasmic protrusions and Rac1
activity at the leading edge to generate traction force, whereas
N-cadherin mediated cell–cell contact at the trailing edge
silences Rac1 and maintains a non-migratory interphase to
the neighboring cells (contact inhibition of migration).45 In
sprouting endothelial cells, VE-cadherin-based cell–cell con-
tact inhibits Rac1 activation through Rho-kinase-dependent
myosin light-chain 2 (MLC2) phosphorylation and thereby
silences FGFR2-mediated protrusion and sprouting at cell-cell
junctions.40 Leading cell polarity further requires non-canonical
Wnt signalling which, via disheveled, activates RhoA
and ROCK.41 Rho/ROCK signaling, in turn, may inhibit
Rac-mediated cytoskeletal protrusions and thereby conﬁne
protrusion formation to regions outside of cadherin-based
junctions. Additional pathways, directly or indirectly, contri-
bute to contact inhibition of migration along cell–cell junc-
tions, including Notch/Delta signaling, engagement of ephrins
and/or atypical cadherins,35 and cell–cell contact through tight
junctions and gap junctions.46 Opposed to the cell–cell contact
zone, the leading edge receives constitutive signals from the
surrounding tissue through receptors that receive input from
ECM and ECM-associated molecules, including integrin
adhesion receptors and growth factor and chemokine
receptors.9,47 In response to ECM, integrins provide transient
adhesion signaling and cytoskeletal mechanotransduction
through intracellular kinases and adapter proteins, including
the focal adhesion kinase (FAK), Src kinases, p130CAS and
paxilin (Table 1).48 These signals result in leading edge
protrusion, adhesive interaction with the substrate and further
enhance adjacent receptor tyrosine kinase (RTK) signaling.49
Intrinsic leading cell polarity may further result from
diﬀerential availability of ECM ligands in front versus rear
parts of migrating groups when ECM is deposited by the
moving cells themselves. In moving keratinocyte sheets,
leading keratinocytes moving towards the wound bed interact
with dermal collagen together with provisional matrix, such as
ﬁbrin and ﬁbronectin and therefore engage a2b1, a5b1 and
avb3 integrins for adhesion and force generation.8,50 Because
moving keratinocytes remodel the underlying ECM and
synthesize basement membrane components, cells further
rearward interact with newly deposited collagen type IV and
laminin which engage diﬀerent and less promigratory sets
of integrins (a6b1, a6b4).50 Likewise, in sprouting vessels,
tip cells encounter primordial (during morphogenesis) or
provisional (during wound healing) ECM whereas stalk cells
move on a basement membrane that is newly deposited along-
side the invading vessel strand.51,52 Thus, diﬀerential substrate
availability contributes to intrinsic polarity in collective
migration. Similar mechanisms of intrinsic polarity are present
during collective cancer cell invasion. Here, leading cancer
cells engage with native interstitial collagen which they sub-
sequently degrade using MT1-MMP/MMP14; consequently
the front part engages with native ECM whereas rearward
parts of the tip cell, like following cells in the strand, con-
tact partially degraded and restructured collagen.7,13 Thus,
pericellular proteolysis generates distinct ECM conditions
along the length axis of the tip cell. Intrinsic bipolarity is
present in all types of tip cells based upon bipolar signaling
from cell-ECM and cell–cell interactions. Because of its
constitutive nature, even in the absence of chemoattractants,
intrinsic polarity may induce and maintain leading edge
functions constitutively and reversibly.
Induced diﬀerentiation
Partial or complete diﬀerentiation into a leading cell can be
induced by extracellular cues, particularly growth factors and
other soluble mediators. Depending on the context, tip cell
fate is induced by RTK signaling, including FGFR, VEGFR
and EGFR and downstream signaling via PI3K, Akt, MAPK
activation and Rho GTPases (Table 1) and, ultimately, altered
gene expression. The diﬀerentiation into single or multiple tip
cells initiates the formation of branched ducts in tracheal
morphogenesis. In Drosophila tracheal morphogenesis, multi-
cellular tracheal ducts form and branch in response to FGF
released by primordial ectodermal and mesodermal cells
adjacent to the tracheal placode.53 As ﬁrst step, FGF binding
to its receptor FGFR, leads to the activation of several intra-
cellular mediators including downstream of FGFR (Dof) and
the tyrosine phosphatase Cockscrew (Csw), to initiate the
membrane-proximal FGFR signaling complex.54,55 Down-
stream FGFR signaling engages the ERK/MAPK pathway
which regulates actin rearrangement and subsequent ﬁlopodia
and lamellipodia extensions.10,54,56 The FGF-induced tip cell
phenotype is maintained by a Ras/MAPK mediated positive
feedback mechanism that upregulates FGFR expression in tip
cells.57 With initial tip cell selection, FGFR signaling is
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inhibited in the neighboring cells through cell–cell contacts,
consistent with a transient diﬀerentiation step. In response to
high FGF levels, tip cells upregulate Delta1 membrane protein
which, in turn, activates its receptor Notch in neighbor cells
and thereby inhibits FGF/MAPK signaling in following
cells.58 Spatial restriction of FGF signaling to tip cells further
involves FGFR-mediated MMP2 expression;59 after its release
MMP2 inhibits FGF-induced ERK phosphorylation in stalk
but not tip cells through an incompletely understood mechanism.
Consequently, in MMP2-/- embryos, ubiquitous FGF/MAPK
signaling prompts ectopic tip cell selection and secondary
tracheal defects.59 Thus an initially not predetermined cell
becomes selected by local growth factor signaling, develops
into a tip cell, and, in turn, inhibits cytoskeletal activity in
neighbor cells.60
Soluble factor-induced selection of tip cells preceding
collective cell migration is recapitulated in other morphogenic
processes, including vascular sprouting, formation of the
lateral line, and migrating border cells. In sprouting angio-
genesis single tip cells that lead the budding of neo-vessels
from preexisting vessels is induced by VEGFR2 signaling
through VEGFA released by stromal cells, including astrocytes,
ﬁbroblasts, or epithelial cells, depending on the context.11,61,62
Migration-promoting VEGFR2 signaling activates Cdc42 and
downstream p21-activated kinase (PAK) for the induction of
ﬁlopodia extension.11 Endothelial tip cells upregulate the
Notch-ligand Dll4 which signals to Notch1 in neighbor cells
and determines stalk cell diﬀerentiation.63–65 Endothelial tip
cells further upregulate VEGFR2 and platelet derived growth
factor B (PDGFB)66 which both stabilize their responsiveness
to environmental guidance. Whereas in sprouting of tracheal
ducts and blood vessels a single or two cells are deﬁned to lead
the group, the lateral line in Zebra ﬁsh is guided by a group of
10 to 20 leader cells along a path deﬁned by SDF-1 released by
the stroma.67,68 The leading group depends upon asymmetric
expression of CXCR4 present in leading and CXCR7 in
trailing cells.6,69 Whereas CXCR4 leads to promigratory
signaling in leading cells, CXCR7 in other parts of the lateral
line is thought to act as a sink for SDF-1 and, hence, a
dominant-negative receptor.69,70 This bipolar expression
CXCR4 and CXCR7 is induced and maintained by diﬀerential
FGF and Wnt/b-catenin signaling.23 Wnt/b-catenin signaling
is conﬁned to tip cells where it induces the paracrine secretion
of FGF which in turn inhibits Wnt/b-catenin signaling in
trailing cells through the Dickkopf-related protein 1 (DKK1).23
In parallel, tip cells silence the FGFR pathway by expressing
the FGF-inhibitor sef.23 Thus, tip cell selection and at least
transient diﬀerentiation result from local growth factor signaling
followed by secondary inhibition of migration activity in
neighboring cells.
Heterocellular-assistance
If a migrating group consists of two or several cell types
with distinct origin or diﬀerentiation state, the leading and
following cells can be from distinct cell lineages. In collective
invasion of epithelial cancer cells in organotypic cultures,
stromal ﬁbroblasts can adopt heterotypic tip cell function
and lead the invasion of the cancer cells.105 Leading ﬁbroblasts
induce matrix remodeling and generate tracks of least resis-
tance by an integrin- and MMP-dependent mechanism.105 The
type of heterocellular cell junctions between leading and
following cells is not clear yet but consistent with concepts
on direct heterotypic cell–cell junctions between cancer and
stromal cells.106–108 Thus, both induced diﬀerentiation and
heterocellular assistance eventually lead to similar outcome,
i.e. a structurally and functionally distinct set of leading cells
to generate mechanotransduction as well as a proteolytic trail
of least resistance.
End bud protrusion
Terminal end buds (TEB) of the mammary gland are highly
proliferative multi-cell layered structures which lead the
branching of mammary ducts. The mechanisms of TEB
movement include high proliferative activity, dynamic cellular
position change within the end bud, and likely the coupling to
a relatively rigid stalk which prevents rearward sliding of
the protruding bud.33 The mechanisms that initiate and
coordinate these distinct functions are not fully understood,
but involve cell-to-cell contacts, cell-ECM interactions and
growth factor signaling. Quiescent mammary epithelial cells
retain direct basolateral contact with myoepithelial cells which
form a continuous layer around the luminal cells and express
the smooth muscle actin and myosin which provide cortical
cytoskeletal stability and contractility.109 Conversely, mammary
duct protrusion and branching mainly takes place in regions
that are devoid from stable contact to myoepithelial cells.
Myoepithelial cells directly contribute to mammary epithelial
cell diﬀerentiation through heterocellular interactions via
desmosomes and gap junctions and indirectly through the
deposition of several basement membrane components including
laminin-1110–113 and thus likely act as inhibitors of cell protru-
sion formation and tip cell functions. Through a mechanical
mechanism, myoepithelial cells may also prevent epithelial
outgrowth by forming stable cell–cell junctions and by their
own contractility which laterally conﬁnes the emerging duct.32
Consequently, end-bud proliferation and protrusion dynamics
may result from the rareﬁcation or absence of heterotypic
cell–cell contact to myoepithelial cells and contact-dependent
diﬀerentiation and anchoring signals.
In addition, diﬀerential ECM composition surrounding the
end bud and stalk may account for functional control of end
bud protrusion. Mature mammary epithelial ducts are covered
by a thick basement membrane composed of collagen type IV,
laminin-1/5 and ﬁbronectin.114,115 The TEB is surrounded by a
thin, provisional basement membrane containing laminin-1,
collagen IV and, in addition, high levels of hyaluronic
acid.116,117 Besides the basement membrane, diﬀerential
processing of ECM components between TEB and ductal
regions is provided by diﬀerentially expressed MMPs.
MT1-MMP/MMP-14 and MMP-2 are highly expressed by
stromal cells nearby the TEBs, whereas MMP-3 is present
nearby quiescent ducts.118–120 Particularly MMP-2 and
MT1-MMP/MMP-14 are important modiﬁers of the ECM
structure which supports cell migration and proliferation and
reduces adhesive cell anchoring.114,118 End bud protrusion and
ductal elongation are further induced and maintained by
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signaling through growth factors, including IGF-1, EGF,
HGF, BMP and Wnt.21,119,121 The mechanisms by which such
factors diﬀerentially engage end bud versus ductal behavior are
likely diverse and include the induction and maintenance of
cell proliferation and growth as well as diﬀerential cytoskeletal
dynamics leading to tissue invasion. Thus, although end bud
protrusion is likely devoid of deﬁned cell-matrix interactions
but dependent on growth, followed by secondary volume
expansion and forward pushing into an activated stroma,
the principles of a leading cell group in diﬀerential contact
with accessory cells and ECM components are maintained, as
in other types of collective cell invasion.
Conclusions
The diverse and often synergistic mechanisms which select and
maintain leader cell functions in collective migration all serve
to generate and maintain a bipolar state near the protruding
leading edge without compromising cell–cell contacts and
structural stability in following cells and, hence, organized
tissue geometry. Thereby contact-dependent and paracrine
signaling by cell–cell junctions and locally released factors
cooperate in a space-restricted context to generate supracellular
coordination of group polarity and tissue organization.
Likely, morphogenetic invasion is recapitulated during cancer
invasion in a very similar albeit less stringently controlled
fashion. Thus, the acquisition of mesenchymal properties with
retained cadherin-based cell–cell junctions likely overlap, or
are identical with, leading-cell function and diﬀerentiation in
morphogenesis. Thus concepts derived from morphogenic
collective invasion may allow to reconcile collective cell
functions with the concept of EMT in cancer progression. In
both, morphogenesis and cancer, tip cells likely retain a
specialized repertoire of activation and diﬀerentiation markers
which might be amenable to targeted therapy to either support
tissue regeneration or inhibit destructive cancer invasion.
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